Previous 10 | Next 10 |
Gainers: Melinta Therapeutics (NASDAQ: MLNT ) +180% . Arcturus Therapeutics (NASDAQ: ARCT ) +37% . Hebron Technology (NASDAQ: HEBT ) +26% . MYOS RENS Technology (NASDAQ: MYOS ) +22% . Armata Pharmaceuticals (NYSEMKT: ARMP ) +19% . AquaBounty Technologies (NASDAQ: AQB ) +19% . D...
Melinta Therapeutics (NASDAQ: MLNT ) +98% on FDA approval of BAXDELA sNDA. More news on: Melinta Therapeutics, Inc., MYOS RENS Technology Inc., Axalta Coating Systems Ltd., Stocks on the move, Read more ...
The FDA has accepted Melinta Therapeutics' (NASDAQ: MLNT ) supplemental New Drug Application (sNDA) for BAXDELA (delafloxacin) for priority review. More news on: Melinta Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...
~ Application Seeks to Expand Label to Include an Indication and Phase III Data for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia (CABP) ~ ~ PDUFA Date Set for October 24, 2019 ~ MORRISTOWN, N.J., June 19, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, ...
Gainers: Bluegreen Vacations (NYSE: BXG ) +35% . ArQule (NASDAQ: ARQL ) +34% . Avadel Pharmaceuticals (NASDAQ: AVDL ) +20% . Moxian (NASDAQ: MOXC ) +17% . Outlook Therapeutics (NASDAQ: OTLK ) +17% . BBX Capital (NYSE: BBX ) +15% . Puyi (NASDAQ: PUYI ) +11% . MYOS RENS Technolo...
The DISARM Act of 2019 provides the framework needed to stabilize the antimicrobial ecosystem, spur development of new infection-fighting drugs, and preserve the effectiveness of existing medicines for drug-resistant infections WASHINGTON , June 7, 2019 /PRNewswire/ -- The Antimi...
Someone’s sitting in the shade today because someone planted a tree a long time ago. - Warren Buffett Writing about antibiotic innovators is a quandary for me because I have to balance between the need for investment profits for investors vs. my social responsibility. It's an inte...
Gainers: Charles & Colvard (NASDAQ: CTHR ) +34% . Buckeye Partners (NYSE: BPL ) +28% . Cardlytics (NASDAQ: CDLX ) +26% . G1 Therapeutics (NASDAQ: GTHX ) +24% . Westport Fuel Systems (NASDAQ: WPRT ) +21% . Cool Holdings (NASDAQ: AWSM ) +22% . Guardant Health (NASDAQ: GH ) +...
Melinta Therapeutics, Inc. (MLNT) Q1 2019 Earnings Conference Call May 9, 2019 4:30 PM ET Company Participants Susan Blum – Vice President-Finance and Chief Accounting Officer John Johnson – Chief Executive Officer Tim Simon – Chief Commercial Officer Peter...
Melinta Therapeutics (NASDAQ: MLNT ): Q1 GAAP EPS of -$2.34 beats by $2.67 . More news on: Melinta Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Melinta Therapeutics Inc - Ordinary Shares Company Name:
MLNT Stock Symbol:
NASDAQ Market:
Melinta Therapeutics Inc - Ordinary Shares Website:
MORRISTOWN, N.J., June 24, 2020 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (“Melinta”), a commercial-stage antibiotics company, announced that on June 24, 2020, pursuant to the Agreement and Plan of Merger by and among Melinta, Toronto Transaction Corp. (“Purch...
Company Enters Growth Phase in Hospital Market with Support of Deerfield Acquisition to Augment Company’s Core Antibiotic Portfolio MORRISTOWN, N. J. , June 09, 2020 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (“Melinta”), a commercial-stage antibiotic...
Bids due on March 2, 2020 by 4:00 p.m. Eastern Time Company Previously Announced Agreement of its Secured Lenders to Acquire Company as Going Concern, Subject to Higher and Better Offers Company Continues Operations with No Anticipated Disruption to Product Supply or Support MO...